MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fine, J. S.
Right arrow Articles by Silverstone, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fine, J. S.
Right arrow Articles by Silverstone, A. E.

Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin

JS Fine, TA Gasiewicz and AE Silverstone

Department of Biophysics, University of Rochester School of Medicine, New York 14642.

Perinatal exposure of experimental animals to the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) leads to thymic atrophy and a suppression of cell-mediated immunity that is more severe and persistent than that caused by adult exposure, suggesting that events involved in the maturation of the immune system are particularly sensitive to TCDD. We report here that perinatal TCDD exposure produces an alteration in the lymphocyte stem cell population in the fetus and neonate, as evidenced by a significant reduction in the lymphocyte stem cell-specific enzyme terminal deoxynucleotidyl transferase (TdT). After maternal treatment with a single dose of TCDD (10 micrograms/kg of body weight) on gestational day (gd) 14, TdT biosynthesis and TdT-specific mRNA were reduced more than 50% in fetal liver lymphoid cells on gd 18. An even more extensive reduction was seen in neonatal bone marrow through postnatal day 18. In contrast, thymic TdT synthesis appeared to be relatively unaffected on a per cell basis by perinatal TCDD exposure, although the actual number of TdT-synthesizing thymocytes was diminished due to extensive thymic atrophy. These effects occurred at concentrations of 1-31 fg of TCDD/mg of thymus. Flow cytometric analysis of thymocyte surface marker expression revealed a slight decrease in the percentage of Lyt-2+L3T4+ thymocytes on gd 18 and postnatal day 4. This alteration was no longer apparent by postnatal day 11, when marrow TdT biosynthesis was most suppressed. These results suggest that TCDD-induced thymic atrophy during the perinatal period may be due, in part, to an effect on the prothymocyte.

Volume 35, Issue 1, pp. 18-25, 01/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Toxicol PatholHome page
D. A. Weinstein, R. M. Gogal Jr, A. Mustafa, M. R. Prater, and S. D. Holladay
Mid-gestation Exposure of C57BL/6 Mice to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Causes Postnatal Morphologic Changes in the Spleen and Liver
Toxicol Pathol, July 1, 2008; 36(5): 705 - 713.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. P. Hogaboam, A. J. Moore, and B. P. Lawrence
The Aryl Hydrocarbon Receptor Affects Distinct Tissue Compartments during Ontogeny of the Immune System
Toxicol. Sci., March 1, 2008; 102(1): 160 - 170.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
I. A. Camacho, M. Nagarkatti, and P. S. Nagarkatti
Evidence for Induction of Apoptosis in T Cells from Murine Fetal Thymus following Perinatal Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)
Toxicol. Sci., March 1, 2004; 78(1): 96 - 106.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. D. Laiosa, Z.-W. Lai, T. S. Thurmond, N. C. Fiore, C. DeRossi, B. C. Holdener, T. A. Gasiewicz, and A. E. Silverstone
2,3,7,8-Tetrachlorodibenzo-p-dioxin Causes Alterations in Lymphocyte Development and Thymic Atrophy in Hemopoietic Chimeras Generated from Mice Deficient in ARNT2
Toxicol. Sci., September 1, 2002; 69(1): 117 - 124.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
R J Smialowicz
The rat as a model in developmental immunotoxicology
Human and Experimental Toxicology, September 1, 2002; 21(9-10): 513 - 519.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
S D Holladay and B L Blaylock
The mouse as a model for developmental immunotoxicology
Human and Experimental Toxicology, September 1, 2002; 21(9-10): 525 - 531.
[Abstract] [PDF]


Home page
Toxicol Ind HealthHome page
Regulations and Advisories
Toxicology and Industrial Health, April 1, 2000; 16(3-5): 173 - 201.
[PDF]


Home page
Mol. Pharmacol.Home page
S. M. Heidel, K. Holston, J. T.M. Buters, F. J. Gonzalez, C. R. Jefcoate, and C. J. Czupyrynski
Bone Marrow Stromal Cell Cytochrome P4501B1 Is Required for Pre-B Cell Apoptosis Induced by 7,12-Dimethylbenz[a]anthracene
Mol. Pharmacol., December 1, 1999; 56(6): 1317 - 1323.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J. E. Staples, F. G. Murante, N. C. Fiore, T. A. Gasiewicz, and A. E. Silverstone
Thymic Alterations Induced by 2,3,7,8-Tetrachlorodibenzo- p-Dioxin Are Strictly Dependent on Aryl Hydrocarbon Receptor Activation in Hemopoietic Cells
J. Immunol., April 15, 1998; 160(8): 3844 - 3854.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics